The House Small Business Committee is waiving jurisdiction over the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act (HR 3884), making it the second House committee in the 116th Congress to advance legislation to end federal marijuana prohibition.
“This … will make it possible for thousands of residents now and in the future to truly be able to turn the corner and not have long forgotten mistakes marking them like a ‘scarlet letter’ for the rest of their lives.”
In the FY2020 appropriations package released Monday, existing protections for medical cannabis programs from federal prosecutors that have been in place since 2014 remained, but other amendments that had been added earlier in the year by House Democrats were removed from the final compromise.
Giving Tuesday is the largest global giving day all year and NORML is excited to be a part of this worldwide event! We’ve set a goal to raise $10,000. It’ll take everyone to get it done, but the impact your donations will have is going to be incredible.
We’re so thankful for all of you.
“This is a truly historic moment in our nation’s political history. For the first time, a Congressional committee has approved far-reaching legislation to not just put an end to federal marijuana prohibition, but to address the countless harms our prohibitionist policies have wrought, notable on communities of color and other already marginalized groups.”
New Jersey Senate President Steve Sweeney and Senate Judiciary Chairman Nicholas Scutari announced today they were moving away from their previous plans to approve legislation to end the state’s failed prohibition on marijuana this year in the state legislature and are instead planning to put a question regarding a constitutional amendment to legalize marijuana before state voters during the 2020 election.
The House Judiciary Committee has posted a markup date for HR 3884, the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act.
CBD-infused products sold online frequently possess significantly lower percentages of CBD than advertised, according to a report published by the online watchdog group LegitScript.com. Investigators lab-tested 30 CBD products obtained from leading online retailers. Twenty of the thirty products possessed significant deviations in CBD content as compared to what was advertised. Sixteen of the 20 products contained lower percentages of CBD than the amount stated on the product’s label — a finding that is consistent with prior analyses. Some of the products also tested positive for the presence of solvent residue and elevated levels of heavy metals – findings that are also consistent with those of other studies. Authors also evaluated the marketing practices of 300 leading online CBD retailers…. Read More
Sixty-two percent of respondents endorsed legalization and 69 percent of respondents said that they supported allowing the substance to be sold at retail via state-licensed stores.
